Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
about
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.A VSV-based Zika virus vaccine protects mice from lethal challengeAdvances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
P2860
Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@ast
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@en
type
label
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@ast
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@en
prefLabel
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@ast
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@en
P2860
P50
P356
P1476
Characterization of a Bivalent ...... s-clade H5N1 Influenza in Mice
@en
P2860
P304
P356
10.1093/INFDIS/JIV257
P407
P478
212 Suppl 2
P577
2015-05-28T00:00:00Z